Gunhild Waldemar, Alistair Burns
Oxford University Press, 2009 - Medical - 106 pages
Alzheimer's disease is a progressive, degenerative and irreversible brain disorder that causes significant neurological impairment. The condition is closely associated with ageing, and it is estimated that 2-5% of people over 65 years of age and up to 20% of those over 85 years of age sufferfrom the disease. Although the disorder is well characterised neuropathologically, accurate diagnosis can be problematic for the clinician.Part of the Oxford Neuropsychiatry Library series, this practical pocketbook will summarise the latest understanding of the possible causes of the disease, the methods of diagnosis and assessment, and current management techniques. The book will also include helpful chapters on supporting thepatient/caregiver and safety/legal issues.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Epidemiology of Alzheimers disease
Diagnosing Alzheimers disease
2 other sections not shown
activities of daily Alzheimer Disease Alzheimer's disease amyloid plaques amyloid precursor protein apathy apolipoprotein assessment associated atrophy behavioural and psychological behavioural symptoms BPSD capacity carers cause ChEls cholinergic cholinesterase inhibitors clinical co-morbidity cognitive decline cognitive deficits cognitive function daily living dementia syndrome depression diagnosis disclosure diagnosis of Alzheimer's diagnosis of dementia disease management disorders donepezil driving drugs E4 allele early effect enzyme episodic memory evaluation evidence executive functions Fratiglioni Frontotemporal dementia galantamine gene genetic Health hypothesis important increased inflammatory intervention issues memantine metabolism microtubule mild cognitive impairment mutations neurodegenerative neurofibrillary tangles Neurology neuronal neuropathology neuropsychiatric nursing homes onset pathology patients with mild person with dementia physical physician placebo power of attorney presenilin prevalence progressive protein psychiatric psychological symptoms psychosocial receptor reduce rivastigmine social specific stages strategies studies symptoms of dementia tests therapy treatment trials vascular dementia vascular risk factors